- Home
- WBX vs LUCD Comparison
WBX vs LUCD Comparison
Compare WBX & LUCD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WBX
- LUCD
- Stock Information
- Founded
- WBX 2015
- LUCD 2018
- Country
- WBX Spain
- LUCD United States
- Employees
- WBX N/A
- LUCD N/A
- Industry
- WBX Industrial Specialties
- LUCD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- WBX Consumer Discretionary
- LUCD Health Care
- Exchange
- WBX Nasdaq
- LUCD Nasdaq
- Market Cap
- WBX 118.0M
- LUCD 108.0M
- IPO Year
- WBX N/A
- LUCD 2021
- Fundamental
- Price
- WBX $6.16
- LUCD $1.17
- Analyst Decision
- WBX Buy
- LUCD Strong Buy
- Analyst Count
- WBX 4
- LUCD 5
- Target Price
- WBX $10.50
- LUCD $3.70
- AVG Volume (30 Days)
- WBX 40.7K
- LUCD 1.4M
- Earning Date
- WBX 11-05-2025
- LUCD 11-12-2025
- Dividend Yield
- WBX N/A
- LUCD N/A
- EPS Growth
- WBX N/A
- LUCD N/A
- EPS
- WBX N/A
- LUCD N/A
- Revenue
- WBX $173,788,608.00
- LUCD $4,360,000.00
- Revenue This Year
- WBX N/A
- LUCD $13.90
- Revenue Next Year
- WBX $46.25
- LUCD $163.88
- P/E Ratio
- WBX N/A
- LUCD N/A
- Revenue Growth
- WBX N/A
- LUCD 14.74
- 52 Week Low
- WBX $3.69
- LUCD $0.75
- 52 Week High
- WBX $23.80
- LUCD $1.80
- Technical
- Relative Strength Index (RSI)
- WBX 68.18
- LUCD 57.08
- Support Level
- WBX $6.00
- LUCD $1.00
- Resistance Level
- WBX $7.83
- LUCD $1.26
- Average True Range (ATR)
- WBX 0.54
- LUCD 0.05
- MACD
- WBX 0.17
- LUCD 0.02
- Stochastic Oscillator
- WBX 51.46
- LUCD 66.67
About WBX Wallbox N.V.
Wallbox NV is a smart electric vehicle charging and energy management company. It creates a smart charging system combining technology design that manages the communication between the user, vehicle, grid, building, and charger. The company designs, manufactures, and distributes faster, simpler EV charging solutions for residential, business, and public use. Its smart charging product portfolio includes Level 2 alternating current chargers for home and business applications and direct current fast chargers for public applications. The company has three reportable operating segments; Europe, Middle East and Asia (EMEA), its key revenue-generating segment, North America, and Asia-Pacific.
About LUCD Lucid Diagnostics Inc.
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.